NAD+ × bioedgeresearchlabs.com — lab test, April 2026
COA 42602 matches MDx BioAnalytical Laboratory's public record. So this test doesn't rest on our review alone — the lab confirms it too.
42602Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 500 mg · Lab measured 500.15 mg
100% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 125 mg on both the label figure and the measured one.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 42602 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 14 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | MDx BioAnalytical Laboratory's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of NAD+ from bioedgeresearchlabs.com, performed by MDx BioAnalytical Laboratory on April 30, 2026. Reported purity: 99.78%. Net content: 500.15 mg against 500 mg labeled (100% of label). Endotoxins: PASS (≤0.05 EU/mL). Batch 260420NA50010. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of NAD+ from bioedgeresearchlabs.com
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| 052526NAD500 | 3 Aug 2026 | Kovera Labs | 99.749% | 100% | ✓ Lab-verified |
| 260224NA5005 | 11 Mar 2026 | MDx BioAnalytical Laboratory | 99.73% | 101% | ✓ Lab-verified |
| 01122026NAD500 | 16 Jan 2026 | MDx BioAnalytical Laboratory | 99.76% | 101% | ✓ Lab-verified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion